Full text is available at the source.
Novel carbazole-oxadiazole derivatives as anti-α-glucosidase and anti-α-amylase agents: Design, synthesis, molecular docking, and biological evaluation
New carbazole-oxadiazole compounds as inhibitors of enzymes involved in sugar digestion: design, testing, and computer modeling
AI simplified
Abstract
Most of the tested carbazole-oxadiazole derivatives displayed varying degrees of α-glucosidase and α-amylase inhibitory activity, with IC values ranging from 21.39 ± 0.69 to 126.14 ± 6.33 μM.
- Compound 6c exhibited the highest anti-α-glucosidase activity with an IC value of 21.39 ± 0.69 μM.
- Compound 6e showed the most effective anti-α-amylase activity with an IC value of 45.53 ± 1.50 μM.
- Lineweaver-Burk plot analysis indicated that 6c acts as a mixed inhibitor of α-glucosidase.
- 6e was identified as a mixed inhibitor of α-amylase.
- Molecular docking simulations suggested specific interaction mechanisms for both 6c and 6e with their target enzymes.
- The potential for reducing postprandial blood glucose levels, along with favorable oral activity and low cytotoxicity, supports the consideration of these compounds as lead candidates for new hypoglycemic agents.
AI simplified